| scholarly article | Q13442814 |
| P2093 | author name string | William J Brown | |
| Andrea J Linscott | |||
| P2860 | cites work | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 |
| Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center | Q24653870 | ||
| A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 | ||
| Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics | Q33647947 | ||
| beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. | Q33693251 | ||
| Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate | Q33752745 | ||
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
| Cephamycin Resistance in Clinical Isolates and Laboratory-derived Strains ofEscherichia coli, Nova Scotia, Canada | Q34548992 | ||
| Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens | Q34708485 | ||
| Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes | Q35006613 | ||
| Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. | Q35122518 | ||
| Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain | Q35138799 | ||
| Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase | Q35264577 | ||
| Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy | Q35922116 | ||
| Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward | Q37511391 | ||
| Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States | Q37734137 | ||
| Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. | Q39664817 | ||
| Characterization of beta-lactamases in situ on polyacrylamide gels | Q39851784 | ||
| Molecular epidemiology of a nosocomial outbreak due to SHV-4-producing strains of Citrobacter diversus | Q40014574 | ||
| TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function | Q40538157 | ||
| Origin and impact of plasmid-mediated extended-spectrum beta-lactamases | Q40569192 | ||
| Molecular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a French hospital | Q45067849 | ||
| Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins. | Q54404338 | ||
| Invasive disease due to extended spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: the possible role of cockroaches | Q57426680 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1081-1085 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests | |
| P478 | volume | 43 |
| Q34741114 | Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q38475591 | Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates |
| Q35090146 | Expert systems in clinical microbiology |
| Q34747622 | Extended spectrum B-lactamase mediated resistance in Escherichia coli in a tertiary care hospital |
| Q54439037 | Extended-spectrum beta-lactamase-producing Escherichia coli isolated in the Al-Amiri Hospital in 2003 and compared with isolates from the Farwania hospital outbreak in 1994-96 in Kuwait. |
| Q48705207 | Multidrug-resistant Gram-negative bacilli in the wastewater of a Lebanese hospital: Profiles and mechanisms of resistance |
| Q42565997 | Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. |
| Q49697152 | The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection |
| Q35220822 | Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria |
| Q42130010 | Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. |
Search more.